Novo Nordisk
NVO
NVO
1,466 hedge funds and large institutions have $21.2B invested in Novo Nordisk in 2025 Q2 according to their latest regulatory filings, with 138 funds opening new positions, 572 increasing their positions, 564 reducing their positions, and 159 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $22.9B → $21.2B (-$1.67B)
13% less first-time investments, than exits
New positions opened: 138 | Existing positions closed: 159
30% less call options, than puts
Call options by funds: $1.14B | Put options by funds: $1.63B
Holders
1,466
Holding in Top 10
24
Calls
$1.14B
Puts
$1.63B
Top Buyers
| 1 | +$297M | |
| 2 | +$145M | |
| 3 | +$136M | |
| 4 |
ClearBridge Investments
New York
|
+$110M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$86M |
Top Sellers
| 1 | -$332M | |
| 2 | -$239M | |
| 3 | -$223M | |
| 4 |
D.E. Shaw & Co
New York
|
-$179M |
| 5 |
JPMorgan Chase & Co
New York
|
-$150M |
